Approved for adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) harboring a PDGFRA exon 18 mutation, including D842V, and for adults with advanced systemic mastocytosis (including aggressive SM, SM with an associated hematologic neoplasm, or mast cell leukemia) driven by KIT D816V or other susceptible mutations.